Literature DB >> 34151319

TextEssence: A Tool for Interactive Analysis of Semantic Shifts Between Corpora.

Denis Newman-Griffis1, Venkatesh Sivaraman2, Adam Perer2, Eric Fosler-Lussier3, Harry Hochheiser1,4.   

Abstract

Embeddings of words and concepts capture syntactic and semantic regularities of language; however, they have seen limited use as tools to study characteristics of different corpora and how they relate to one another. We introduce TextEssence, an interactive system designed to enable comparative analysis of corpora using embeddings. TextEssence includes visual, neighbor-based, and similarity-based modes of embedding analysis in a lightweight, web-based interface. We further propose a new measure of embedding confidence based on nearest neighborhood overlap, to assist in identifying high-quality embeddings for corpus analysis. A case study on COVID-19 scientific literature illustrates the utility of the system. TextEssence can be found at https://textessence.github.io.

Entities:  

Year:  2021        PMID: 34151319      PMCID: PMC8212692     

Source DB:  PubMed          Journal:  Proc Conf


  22 in total

1.  Aggregating UMLS semantic types for reducing conceptual complexity.

Authors:  A T McCray; A Burgun; O Bodenreider
Journal:  Stud Health Technol Inform       Date:  2001

2.  The Unified Medical Language System (UMLS): integrating biomedical terminology.

Authors:  Olivier Bodenreider
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

3.  BioConceptVec: Creating and evaluating literature-based biomedical concept embeddings on a large scale.

Authors:  Qingyu Chen; Kyubum Lee; Shankai Yan; Sun Kim; Chih-Hsuan Wei; Zhiyong Lu
Journal:  PLoS Comput Biol       Date:  2020-04-23       Impact factor: 4.475

Review 4.  Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review.

Authors:  Mukhtar H Ahmed; Arez Hassan
Journal:  SN Compr Clin Med       Date:  2020-10-31

5.  Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir.

Authors:  Hamid Rahmani; Effat Davoudi-Monfared; Anahid Nourian; Morteza Nabiee; Setayesh Sadeghi; Hossein Khalili; Ladan Abbasian; Fereshteh Ghiasvand; Arash Seifi; Malihe Hasannezhad; Sara Ghaderkhani; Mostafa Mohammadi; Mir Saeed Yekaninejad
Journal:  Daru       Date:  2020-08-28       Impact factor: 3.117

6.  The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19.

Authors:  Alessandro Gozzetti; Enrico Capochiani; Monica Bocchia
Journal:  Leukemia       Date:  2020-09-02       Impact factor: 11.528

7.  Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study.

Authors:  Andrew Ip; Donald A Berry; Eric Hansen; Andre H Goy; Andrew L Pecora; Brittany A Sinclaire; Urszula Bednarz; Michael Marafelias; Scott M Berry; Nicholas S Berry; Shivam Mathura; Ihor S Sawczuk; Noa Biran; Ronaldo C Go; Steven Sperber; Julia A Piwoz; Bindu Balani; Cristina Cicogna; Rani Sebti; Jerry Zuckerman; Keith M Rose; Lisa Tank; Laurie G Jacobs; Jason Korcak; Sarah L Timmapuri; Joseph P Underwood; Gregory Sugalski; Carol Barsky; Daniel W Varga; Arif Asif; Joseph C Landolfi; Stuart L Goldberg
Journal:  PLoS One       Date:  2020-08-13       Impact factor: 3.752

8.  Effects of dexamethasone in traumatic brain injury patients with pericontusional vasogenic edema: A prospective-observational DTI-MRI study.

Authors:  Apolonia Moll; Mónica Lara; Jaume Pomar; Mónica Orozco; Guiem Frontera; Juan A Llompart-Pou; Lesmes Moratinos; Víctor González; Javier Ibáñez; Jon Pérez-Bárcena
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

9.  Successfully treated severe COVID-19 and invasive aspergillosis in early hematopoietic cell transplantation setting.

Authors:  Manuela Spadea; Francesca Carraro; Francesco Saglio; Elena Vassallo; Rosanna Pessolano; Massimo Berger; Carlo Scolfaro; Sergio Grassitelli; Franca Fagioli
Journal:  Transpl Infect Dis       Date:  2020-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.